PEPTIDEREPORT

FDA · Enforcement

Gram Peptides: FDA Warning Letter 721806

The FDA said Gram Peptides marketed unapproved new drugs for human use despite research-only labeling. Warning letter 721806 details the finding.

Agency warning legal stageMar 31, 2026 record dateUnited States jurisdiction
Open the primary-source record

Record status

Open public record

Agency
U.S. Food and Drug Administration
Action
Warning letter
Stage
Agency warning
Last verified
Jul 10, 2026

Source-backed timeline

Status history

  1. Warning letter issuedSource

Editorial boundary: Peptide Report summarizes the public source and preserves its procedural stage. This page does not convert an allegation, proposal, advisory discussion, or warning into a final legal conclusion.

Back to all Regulatory Watch records